Cargando…
Can Corticosteroids be Used as a First-Line Agent for Mercury-Related Glomerular Diseases?
Autores principales: | Mattewada, Naveen Kumar, Priyamvada, P.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403667/ https://www.ncbi.nlm.nih.gov/pubmed/37547523 http://dx.doi.org/10.1016/j.ekir.2023.05.031 |
Ejemplares similares
-
Recognizing the importance of physical activity on sarcopenia in chronic kidney disease - Reply
por: Dubey, Avinash Kumar, et al.
Publicado: (2022) -
Role of Urinary Beta 2 Microglobulin and Kidney Injury Molecule-1 in Predicting Kidney Function at One Year Following Acute Kidney Injury
por: Puthiyottil, Dhanin, et al.
Publicado: (2021) -
Levetiracetam as a First-line Agent for Neonatal Seizure
por: Mandal, Anirban, et al.
Publicado: (2017) -
What can we learn about corticosteroid therapy as a treatment for COVID-19?
por: Tang, J.
Publicado: (2020) -
Corticosteroids and rehabilitation in COVID-19 survivors
por: Lal, Amos, et al.
Publicado: (2021)